Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Immunol Res ; 2017: 8959687, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29318161

RESUMO

The goal of the present study was to determine whether peptidylarginine deiminase PAD2 and PAD4 enzymes are present in Balb/c mouse salivary glands and whether they are able to citrullinate Ro and La ribonucleoproteins. Salivary glands from Balb/c mice were cultured in DMEM and supplemented with one of the following stimulants: ATP, LPS, TNF, IFNγ, or IL-6. A control group without stimulant was also evaluated. PAD2, PAD4, citrullinated peptides, Ro60, and La were detected by immunohistochemistry and double immunofluorescence. PAD2 and PAD4 mRNAs and protein expression were detected by qPCR and Western blot analysis. PAD activity was assessed using an antigen capture enzyme-linked immunosorbent assay. LPS, ATP, and TNF triggered PAD2 and PAD4 expression; in contrast, no expression was detected in the control group (p < 0.001). PAD transcription slightly increased in response to stimulation. Additionally, PAD2/4 activity modified the arginine residues of a reporter protein (fibrinogen) in vitro. PADs citrullinated Ro60 and La ribonucleoproteins in vivo. Molecular stimulants induced apoptosis in ductal cells and the externalization of Ro60 and La ribonucleoproteins onto apoptotic membranes. PAD enzymes citrullinate Ro and La ribonucleoproteins, and this experimental approach may facilitate our understanding of the role of posttranslational modifications in the pathophysiology of Sjögren's syndrome.


Assuntos
Autoantígenos/metabolismo , Hidrolases/metabolismo , Desiminases de Arginina em Proteínas/metabolismo , Ribonucleoproteínas/metabolismo , Glândulas Salivares/fisiologia , Síndrome de Sjogren/metabolismo , Trifosfato de Adenosina/imunologia , Animais , Apoptose , Células Cultivadas , Citrulinação , Citocinas/metabolismo , Ativação Enzimática , Fibrinogênio/metabolismo , Regulação da Expressão Gênica , Humanos , Hidrolases/genética , Mediadores da Inflamação/metabolismo , Lipopolissacarídeos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Proteína-Arginina Desiminase do Tipo 2 , Proteína-Arginina Desiminase do Tipo 4 , Desiminases de Arginina em Proteínas/genética , Antígeno SS-B
2.
Clin Dev Immunol ; 13(2-4): 163-6, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17162359

RESUMO

In subacute cutaneous lupus eryhematosus (SCLE) the cutaneous antigens constitute the main source of Ro and La autoantigens. The aim of this investigation was to demonstrate if UV light increases the availability of Ro autoantigen in the skin, also the blocking effect of Ac-DEVD-CMK a caspase inhibitor was assessed. For this purpose newborn Balb/c mice were UVB irradiated (5-30 mJ/cm(2)) equivalent to a moderate to severe sunburn. Animals were injected with monoclonal anti-Ro antibodies from SCLE patients. Apoptosis was also induced by anti-Fas antibody injection. Skin samples were examined by direct immunofluoresence, by TUNEL, and the expression of caspase 3 by RT-PCR. Major findings of present studies were: 1. UVB irradiation and anti-Fas induced apoptosis of keratinocytes. 2. Apoptosis redistribute the Ro antigen on cell surface and is better triggered by Ro antibody. 3. The caspase 3 inhibitor Ac-DEVD-CMK decreases the availability of Ro autoantigen in epidermis and prevents deposition of anti-Ro. In conclusion, the caspase pathway would be blocked to avoid anti-Ro deposition along skin; this finding would be a prospect in the treatment of SCLE patients.


Assuntos
Apoptose , Autoanticorpos/administração & dosagem , Lúpus Eritematoso Cutâneo/metabolismo , Lúpus Eritematoso Cutâneo/patologia , Transtornos de Fotossensibilidade/etiologia , Ribonucleoproteínas/metabolismo , Raios Ultravioleta , Clorometilcetonas de Aminoácidos/farmacologia , Animais , Apoptose/fisiologia , Relação Dose-Resposta à Radiação , Lúpus Eritematoso Cutâneo/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Ribonucleoproteínas/imunologia , Pele/efeitos dos fármacos , Pele/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA